Alembic Limited

Nurturing global well being since 1907

Presented By:Avni Jain (20)

Mission:

We always intend to give access to the best healthcare products at affordable price to

everyone, anywhere in the world

About

Alembic started in 1907 Asia's most respected integrated pharmaceutical company Regd. Office: Alembic Road, Vadodara Manufacturing facilities in Baroda and Baddi, India Operations:

Domestic Formulation Sales Export Formulations Domestic API sales Export API Contract/ collaborated Research Services

Promoters: No. of shares held: 8,47,53,005 % of voting strength: 61.78

The Board has recommended dividend on Equity Shares at Rs.0.40 per share i.e.20% for the year ended on 31.03.2009

Certification Alembic is a certified

ISO-9002 , ISO-14001 and ISO 27001

Conforms to WHO-GMP guidelines ensuing that every Alembic product meets the most stringent quality standards.

Albemic group of companies Shreno Limited [Glass Division]  

Shreno Limited [Engg. Division]

Paushak Limited

Restructuring and its key benefits Alembic went a

restructuring in this fiscal year to streamline

products into tighter well- focused segments

sharpen the effectiveness of the sales force

Growth Ignitions Alembic released 34

new products in 2008-09 compared to 25 in 2007-08

Contributed 3.54% to the domestic branded formulations sales

Brand Domination Azithral

consolidated its No. 1 position in its category recorded a 30% growth. It also catapulted 12 places from its last year rank

of 39 to become the 27th top selling brand in the country.*

* Source: ORG (MAT),March '09.

Top ten brands

* Source: ORG (MAT),March '09.

R & D The total investment in R&D this year was Rs. 47.7 Crores,

which was 4.21% of consolidated net sales.

Alembic Research Centre is 1,45,000 sq. Ft. build on state of art

It houses 250+ scientists

IPR “IPR Knowledge Contribution to Society

Enhancement” initiative was launched to focus on enhancing IPR competency across the organization.

This year Alembic accelerated its patent filing process by filing 54 patent applications

International Footprint

Financial Highlights 2008-09

• 10.4% increase in total revenue

• 44% growth in International Business

• 71% growth in sales to regulated markets

• 54% growth in API sales

• 34 new domestic formulations product launched

• 6 of the domestic brands featured amongst ORG top 300 brands

• 14th most prescribed Company by Indian doctors

• 10.4% increase in total revenue

• 44% growth in International Business

• 71% growth in sales to regulated markets

• 54% growth in API sales

• 34 new domestic formulations product launched

• 6 of the domestic brands featured amongst ORG top 300 brands

• 14th most prescribed Company by Indian doctors

Share Price and Sensex

Listing of Shares Bombay Stock Exchange Limited (BSE)

National Stock Exchange of India Limited (NSE)

Work Culture at Albemic• Share collaborative & symbiotic relationships with

our employees.

• The environment at Alembic can be defined as positive, built on mutual strengths.

• They value openness and teamwork in our interpersonal dealings.

   

Thank You